Patients recovering from COVID-19 can experience a range of long-term post-acute effects. The potential clinical and economic burden of these outcomes is unclear. This study, published by BMC Medicine in the USA in 2023, evaluated diagnoses, medications, healthcare utilisation, and medical costs before and after acute COVID-19 illness in US patients who were not at high risk of severe COVID-19.
The results showed that those who were hospitalised, with or without ICU admission, during the acute phase had the greatest increases in comorbidities and healthcare resource utilisation. However, the burden was apparent across all cohorts. The conclusion as evidenced by resource use in the post-acute phase, COVID-19 places a significant long-term clinical and economic burden among US individuals, even among patients whose acute infection did not merit hospitalisation.
You can read the study here.
Durham County Department of Public Health have produced a great video demonstrating that covid and many other viruses are airborne. The video is less than two minutes long. An airborne virus is a virus that can infect other people through particles in the air, sometimes for hours after the sick person has left the area! […]
This narrative review shows that POTS, ME/CFS and Long COVID are closely related conditions that share common biological mechanisms. The authors explain that problems with the autonomic nervous system, immune dysregulation and autoimmunity, mitochondrial dysfunction, reduced blood flow to the brain, and neuroinflammation all play a role. POTS and ME/CFS are identified as the most […]
Summary: Comparing Long Covid symptoms between patients that received COVID-19 vaccinations and those that did not. Study by Pasculli et. al., (2025) summarised by Amanda Harrington-Vail Introduction Since the COVID-19 pandemic was officially declared, almost 780 million cases and nearly 7 million deaths have been reported worldwide. Although COVID-19 vaccination has reduced the risk of […]
